Phathom Pharmaceuticals(PHAT)
$6.06-0.17 (-2.73%)
PHAT
Phathom Pharmaceuticals earnings date
$6.06
At close:-0.17 (-2.73%)
Want to see PHAT full AI Analyst Report?
Phathom Pharmaceuticals (PHAT) Q2 2026 Earnings Report
608 Followers
PHAT Q2 2026 EPS Results
- Actual EPS
- -$0.21
- Consensus EPS
- -$0.18
- Beat/Miss
- Missed by -$0.03
- One Year Ago EPS
- -$1.05
PHAT Q2 2026 Revenue Results
- Actual Revenue
- $74.27M
- Expected Revenue
- $73.23M
- Beat/Miss
- Beat by +$1.04M
- YoY Revenue Growth
- +88.02%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/30/2026
- Time
- Before Open
- Conference Call
- Thursday, July 30, 2026
PHAT Upcoming Earnings
Phathom Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
PHAT Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
PHAT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.07- | -0.29 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.11-0.16 | -0.41 | 60.98% (+0.25) | |
| Jul 30, 2026 | 2026 (Q2) | -0.18-0.21 | -1.05 | 80.00% (+0.84) | |
| Apr 30, 2026 | 2026 (Q1) | -0.29-0.37 | -1.31 | 71.76% (+0.94) | |
| Feb 26, 2026 | 2025 (Q4) | -0.41-0.29 | -1.05 | 72.38% (+0.76) | |
| Oct 30, 2025 | 2025 (Q3) | -0.46-0.41 | -1.32 | 68.94% (+0.91) | |
| Aug 07, 2025 | 2025 (Q2) | -0.95-1.05 | -1.56 | 32.69% (+0.51) | |
| May 01, 2025 | 2025 (Q1) | -1.10-1.31 | -1.42 | 7.75% (+0.11) | |
| Mar 06, 2025 | 2024 (Q4) | -1.22-1.05 | -1.39 | 24.46% (+0.34) | |
| Nov 07, 2024 | 2024 (Q3) | -1.47-1.32 | -0.76 | -73.68% (-0.56) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


